TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Chiron Pharmasynth AS
Closing information (x1000 DKK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 8,314 | 5,239 | 6,128 |
Financial expenses | 21 | 41 | 101 |
Earnings before taxes | 2,591 | 1,511 | 3,404 |
Total assets | 12,732 | 9,470 | 8,505 |
Current assets | 12,709 | 9,435 | 8,432 |
Current liabilities | 3,803 | 3,239 | 3,709 |
Equity capital | 8,930 | 6,231 | 4,796 |
- share capital | 1,344 | 1,322 | 1,343 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 70.1% | 65.8% | 56.4% |
Turnover per employee | |||
Profit as a percentage of turnover | 31.2% | 28.8% | 55.5% |
Return on assets (ROA) | 20.5% | 16.4% | 41.2% |
Current ratio | 334.2% | 291.3% | 227.3% |
Return on equity (ROE) | 29.0% | 24.2% | 71.0% |
Change turnover | 2,986 | -792 | 2,419 |
Change turnover % | 56% | -13% | 65% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.